ssmuБюллетень сибирской медициныBulletin of Siberian Medicine1682-03631819-3684Siberian State Medical University, the Ministry of Healthcare of the Russian Federation10.20538/1682-0363-2009-2-61-68ssmu-1792Research ArticleЭКСПЕРИМЕНТАЛЬНЫЕ И КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯEXPERIMENTAL AND CLINICAL INVESTIGATIONSЗначение исследования семейного анамнеза при антифосфолипидном синдромеThe role of family anamnesis investigation in antiphospholipid syndromeЧапаеваН. Н.ChapayevaN. N.

Чапаева Наталья Николаевна, д р мед наук профессор кафедры госпитальной терапии и клинической фармакологии лечебного факультета

8-905-959-2655, 8-913-912-2345

n.chapaeva@mail.ruТрифоноваМ. А.TrifonovaM. A.

клинический ординатор кафедры госпитальной терапии и клинической фармакологии лечебного факультета

Новосибирский государственный медицинский университетRussian Federation200928042009826168Copyright © Чапаева Н.Н., Трифонова М.А., 20092009Чапаева Н.Н., Трифонова М.А.Chapayeva N.N., Trifonova M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://bulletin.ssmu.ru/jour/article/view/1792

The investigation of 82 families of patients with antiphospholipid syndrome (APS) was performed. APS was diagnosed in 1st-degree relatives and woman more frequently. Minor features of APS were revealed in half of relatives, lupus anticoagulant (LA) — in a third of them. If person has APS in family anamnesis, minor features of APS or (and) LA, pre-APS can be diagnosed and primary prevention of thrombosis can be conducted.

антифосфолипидный синдромпре-АФСсемейный анамнезantiphospholipid syndromepre-APSfamily anamnesisReferencesВоевода М.И., Максимов В.Н., Малютина С.К. Семейный анамнез и его связь с сердечно-сосудистыми заболеваниями в мужской популяции Новосибирска//Бюл. СО РАМН. 2006. Т. 4. № 122. С. 56-62.Воевода М.И., Максимов В.Н., Малютина С.К. Семейный анамнез и его связь с сердечно-сосудистыми заболеваниями в мужской популяции Новосибирска//Бюл. СО РАМН. 2006. Т. 4. № 122. С. 56-62.Насонов Е.Л. Критерии диагностики и дифференциальной диагностики антифосфолипидного синдрома//Антифосфолипидный синдром. М.: Литтерра, 2004. С. 249-266.Насонов Е.Л. Критерии диагностики и дифференциальной диагностики антифосфолипидного синдрома//Антифосфолипидный синдром. М.: Литтерра, 2004. С. 249-266.Arnett F.C., Reveille J.D., Wilson R.W. et al. Systemic lupus erythematosus: current state of the genetic hypothesis//Semin. Arthritis Rheum. 1984. V. 14. P. 24-35.Arnett F.C., Reveille J.D., Wilson R.W. et al. Systemic lupus erythematosus: current state of the genetic hypothesis//Semin. Arthritis Rheum. 1984. V. 14. P. 24-35.Brandt J.T., Barna L.K., Triplett D.A. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH//Thromb. Haemost. 1995 V. 74. № 6. P. 1597-1603.Brandt J.T., Barna L.K., Triplett D.A. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH//Thromb. Haemost. 1995 V. 74. № 6. P. 1597-1603.D'Cruz. Antiphospholipid (Hughes) syndrome: an overview//Hughes syndrome: antiphospholipid syndrome/M.A. Khamashta (ed.). London: Springer-Verlag, 2006. P. 9-21.D'Cruz. Antiphospholipid (Hughes) syndrome: an overview//Hughes syndrome: antiphospholipid syndrome/M.A. Khamashta (ed.). London: Springer-Verlag, 2006. P. 9-21.Gharavi A.E., Harris E.N., Asherson R.A., Hughes G.R. Anticardiolipin antibodies: isotype distribution and phospholipid specificity//Ann. Rheum. Dis. 1987. V. 46. P. 1-6.Gharavi A.E., Harris E.N., Asherson R.A., Hughes G.R. Anticardiolipin antibodies: isotype distribution and phospholipid specificity//Ann. Rheum. Dis. 1987. V. 46. P. 1-6.Goel N., Ortel T.L., Bali D. et al. Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance//Arthritis Rheum. 1999. V. 42. P. 318-327.Goel N., Ortel T.L., Bali D. et al. Familial antiphospholipid antibody syndrome: criteria for disease and evidence for autosomal dominant inheritance//Arthritis Rheum. 1999. V. 42. P. 318-327.Harris E.N. Syndrome of the black swan//Br. J. Rheum. 1987. V. 26. № 5. P. 324-325.Harris E.N. Syndrome of the black swan//Br. J. Rheum. 1987. V. 26. № 5. P. 324-325.Harris E.N., Pierangeli S.S. Antiphospholipid antibodies and antiphospholipid syndrome//Systemic lupus erythematosus/P.A. Miescher (ed.). Springer, 1995. P. 93-115.Harris E.N., Pierangeli S.S. Antiphospholipid antibodies and antiphospholipid syndrome//Systemic lupus erythematosus/P.A. Miescher (ed.). Springer, 1995. P. 93-115.Hughes G.R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant//BMJ. 1983. V. 287. P. 1088-1089.Hughes G.R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant//BMJ. 1983. V. 287. P. 1088-1089.Hughes G., Harris E.N., Gharavi A. The anticardiolipin syndrome//Rheumatol. 1986. V. 13. P. 486-489.Hughes G., Harris E.N., Gharavi A. The anticardiolipin syndrome//Rheumatol. 1986. V. 13. P. 486-489.Infante R.C., David M., Gauthier R. et al. Lupus anticoagulant, anticardiolipin antibodies, and fetal loss. A case-control study//N. Eng. J. Med. 1991. V. 325. P. 1063-1066.Infante R.C., David M., Gauthier R. et al. Lupus anticoagulant, anticardiolipin antibodies, and fetal loss. A case-control study//N. Eng. J. Med. 1991. V. 325. P. 1063-1066.Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome//N. Eng. J. Med. 2002. V. 346. P. 752-763.Levine J.S., Branch D.W., Rauch J. The antiphospholipid syndrome//N. Eng. J. Med. 2002. V. 346. P. 752-763.Miyakis S., Lockshin M.D., Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)//J. of Thromb. and Haemost. 2006. V. 4. P. 295-306.Miyakis S., Lockshin M.D., Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)//J. of Thromb. and Haemost. 2006. V. 4. P. 295-306.Pattison N.S., Chamley L.W., McKay E.J. et al. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations//Br. J. Obstet. Gynaecol. 1993. V. 100. P. 909-913.Pattison N.S., Chamley L.W., McKay E.J. et al. Antiphospholipid antibodies in pregnancy: prevalence and clinical associations//Br. J. Obstet. Gynaecol. 1993. V. 100. P. 909-913.Piette J.C. Diagnostic and classification criteria for the antiphospholipid syndrome: a «mission» impossible//Lupus. 1996. V. 5. P. 354-363.Piette J.C. Diagnostic and classification criteria for the antiphospholipid syndrome: a «mission» impossible//Lupus. 1996. V. 5. P. 354-363.Piette J.C. Towards improved criteria for the antiphospholipid syndrome//Lupus. 1998. V. 7. Suppl 2. P. 149-157.Piette J.C. Towards improved criteria for the antiphospholipid syndrome//Lupus. 1998. V. 7. Suppl 2. P. 149-157.Rix P., Stentoft J., Aunsholt N.A. et al. Lupus anticoagulant and anticardiolipin antibodies in an obstetric population//Acta Obstet. Gynecol. Scand. 1992. V. 71. P. 605-609.Rix P., Stentoft J., Aunsholt N.A. et al. Lupus anticoagulant and anticardiolipin antibodies in an obstetric population//Acta Obstet. Gynecol. Scand. 1992. V. 71. P. 605-609.Sammaritano L.R., Piette J.C. Pediatric and familial antiphospholipid syndromes//The antiphospholipid syndrome II: autoimmune thrombosis/Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y. (eds). Elsevier, 2002. V. 297-316.Sammaritano L.R., Piette J.C. Pediatric and familial antiphospholipid syndromes//The antiphospholipid syndrome II: autoimmune thrombosis/Asherson R.A., Cervera R., Piette J.C., Shoenfeld Y. (eds). Elsevier, 2002. V. 297-316.Shi W., Krilis S.A., Chong B.H. et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust. N. Z. J. Med. 1990. V. 20. № 3. P. 231-236.Shi W., Krilis S.A., Chong B.H. et al. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust. N. Z. J. Med. 1990. V. 20. № 3. P. 231-236.Roubey R.A.S. Immunology of antiphospholipid antibody syndrome//Arthritis Rheum. 1996. V. 39. P. 1444-1454.Roubey R.A.S. Immunology of antiphospholipid antibody syndrome//Arthritis Rheum. 1996. V. 39. P. 1444-1454.Weber M., Hayem G., DeBandt M. et al. The family history of patients with primary or secondary antiphospholipid syndrome (APS)//Lupus. 2000. V. 9. P. 258-263.Weber M., Hayem G., DeBandt M. et al. The family history of patients with primary or secondary antiphospholipid syndrome (APS)//Lupus. 2000. V. 9. P. 258-263.Wilson W.A., Scopelitis E., Michalski J.P. et al. Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors//J. Rheumatol. 1995. V. 22. № 2. P. 227-235.Wilson W.A., Scopelitis E., Michalski J.P. et al. Familial anticardiolipin antibodies and C4 deficiency genotypes that coexist with MHC DQB1 risk factors//J. Rheumatol. 1995. V. 22. № 2. P. 227-235.Wisloff F., Jacobsen E.N., Liestol S. Laboratory diagnosis of the antiphospholipid syndrome//Thromb. Res. 2002. V. 108. P. 263-267.Wisloff F., Jacobsen E.N., Liestol S. Laboratory diagnosis of the antiphospholipid syndrome//Thromb. Res. 2002. V. 108. P. 263-267.

The authors declare that there are no conflicts of interest present.